There will be another vaccine to give a person, and always another person to provide a vaccine. Meanwhile, states around the country are rapidly changing laws restricting usage of exemptions, while adding laws to require a growing number of vaccines for more and more people, both children and adults. Join the NVIC Advocacy Portal to stay abreast of proposed vaccine laws and regulations around the country, and to support vaccine independence of choice in a state.ALSP is developing new methods to effectively deal with neurodegenerative disease with an initial focus on Alzheimer’s disease . ALSP has identified a new class of drugs that prevent storage pathology and deficit in animal models of AD. Our proprietary lead substance, AB-007, offers previously been evaluated for a different indication in human clinical trials and been shown to be safe and well tolerated, said company CEO, Michael D. Pierschbacher, PhD. Our goal is to conduct scientific trials on AB-007 to confirm as quickly as possible the noticed preclinical efficacy for treatment of Advertisement.